Nootropics Index - Save on smarter supplements
Nootropics>Peptides, proteins & enzymes>Royal jelly
Peptides, proteins & enzymes

Royal jelly

Royal jelly

Royal jelly is a bee-derived secretion sold as powder, capsules, fresh/frozen jelly, or extract. It is not a well-supported nootropic: direct human cognition evidence is weak, while the key buyer safety issue is bee-product allergy, including asthma and anaphylaxis case literature. Compare allergy or asthma history, anticoagulant treatment, product form, dose context, quality testing and whether marketing claims match the limited human evidence.

Food DerivedAnimal DerivedTraditional UseClinical ResearchLimited Human EvidenceMixed EvidenceForm Dependent Evidence
Updated August 2026/5 min read/9 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What it is

1

Royal jelly is a secretion produced by worker bees and fed to larvae and queen bees. Supplements are usually sold as fresh/frozen jelly, freeze-dried powder, capsules, bulk powder or extracts.

Evidence snapshot2
Royal jelly is marketed for energy, memory and healthy-aging, but direct nootropic evidence is weak. Allergy, asthma and anaphylaxis reports are more important for buyer screening than speculative cognitive claims.

Product forms

1

Fresh and freeze-dried forms can differ in water content and marker concentration, so grams are not automatically comparable.

Quality marker

1

10-HDA is commonly used as a royal jelly marker, but a marker claim does not prove clinical equivalence.

Nootropic claims are weak5
Current human evidence does not justify strong memory, focus, energy or cognitive-performance claims. Selected menopause or metabolic studies should be described as population-specific context.
02

Names, aliases and forms

Common NamesRoyal jelly; Bee milk; Royal bee jelly
Active Constituent10-HDA
03

Mechanisms of action

Complex bee-derived matrix

1

Royal jelly is a mixture rather than a single standardized molecule. Composition varies with processing, water content, storage and quality controls.

04

Potential effects and evidence map

Royal jelly has human studies in selected areas such as menopausal symptoms and metabolic markers, but the evidence is mixed and not primarily cognitive. There is no strong human basis for memory, focus, energy or stress claims. The main safety issue is documented IgE-mediated hypersensitivity, including asthma and anaphylaxis reports; a single case report also signals a possible warfarin interaction.

Effect domainMagnitudeGrade
Mood / wellbeing5
CumulativeConfidence: Low

Royal jelly has limited population-specific wellbeing evidence, but not enough for broad mood, stress or nootropic claims.

Note Menopause symptom trials should not be generalized to healthy nootropic use.

1/5
C
Cellular / long-term brain support1
UnknownConfidence: Low

Mechanistic or nutrient-composition arguments do not establish human brain-health benefits.

Note Avoid neuroprotection or healthy-aging claims.

1/5
E
05

Typical dosages and timing

postmenopausal women; eight-week capsule trial51,000 mg/day

One eight-week trial in postmenopausal women used 1,000 mg/day of royal jelly capsules for menopausal symptoms. That population and product do not establish a general nootropic dose or equivalence with fresh jelly, freeze-dried powder or extracts.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
Study window5Cumulative
8 weeks
No established acute cognition window5

No human evidence here establishes a same-day cognitive onset, peak or duration. The eight-week capsule study is a study course, not an effect-duration claim.

07

Safety, side effects and risk profile

Bee-product allergy comes first2
Published reports include asthma and anaphylaxis after oral royal jelly exposure. People with bee-product sensitivity, asthma, atopy or a prior allergic reaction are the most relevant risk group for this product class.
Interaction risk8
Confidence: Low

A single case report described elevated INR and bleeding after royal jelly was added to warfarin. It signals a potentially serious interaction for warfarin users but does not establish frequency, mechanism or a class-wide anticoagulant effect.

Note Targeted interaction concern; it does not set the healthy-adult base risk.

4/5
C
serious allergic reaction risk3documented case literature

Royal jelly has published reports of asthma, community hypersensitivity and anaphylaxis. This is the key safety issue to surface before ordinary side-effect lists.

reported tolerability issues1GI discomfort; facial rash

MSK lists anecdotal gastrointestinal discomfort and facial rash. These reports are less decision-critical than the documented allergy and asthma concern.

08

Interactions and cautions

warfarin; single case report8

A 2006 case report described a raised INR and bleeding after royal jelly was added to stable warfarin therapy. It is a potentially serious signal that warrants medication-interaction screening, but one case cannot establish frequency, mechanism or a class-wide anticoagulant interaction.

09

Legal and regulatory status

United States 2026; no FDA pre-approval9

United States context (as of 2026): if a royal jelly product is marketed as a dietary supplement, FDA does not approve its safety, effectiveness or labeling before sale. That general rule does not determine any individual product's classification, quality or claims.

10

Practical buying and quality notes

  • Allergy or asthma history changes the decision more than price. Published reports include severe hypersensitivity, asthma and anaphylaxis after oral royal jelly exposure.2
  • Fresh/frozen royal jelly, freeze-dried powder, extracts and capsules can differ in moisture, freshness, storage needs and 10-HDA marker claims.1
  • Prefer products with batch testing for identity, microbial quality, heavy metals, adulteration and clear storage guidance. Bulk powders should not rely only on generic bee-product claims.1
11

FAQ

Is royal jelly a nootropic?

5

Not strongly. The human evidence does not support broad memory, focus or productivity claims; selected non-cognitive studies should not be rebranded as nootropic proof.

Who has the clearest safety concern?

2

The most important published concern is IgE-mediated hypersensitivity, including asthma and anaphylaxis, particularly in people with bee-product sensitivity, asthma, atopy or prior allergic reactions.

What should buyers compare?

8

Compare fresh versus freeze-dried form, dose, 10-HDA marker claim, storage instructions, allergen warnings, batch testing and whether the listing overstates brain or healthy-aging benefits. A single warfarin case report is also a reason to check medication compatibility rather than assuming all bee products behave alike.

12

References

  1. Memorial Sloan Kettering Cancer Center. Royal jelly.
  2. Thien FC, Leung R, Baldo BA, Weiner JA, et al. Asthma and anaphylaxis induced by royal jelly. Clin Exp Allergy. 1996;26(2):216-222.
  3. Leung R, Ho A, Chan J, Choy D, et al. Royal jelly consumption and hypersensitivity in the community. Clin Exp Allergy. 1997;27(3):333-336.
  4. Katayama M, Aoki M, Kawana S. Case of anaphylaxis caused by ingestion of royal jelly. J Dermatol. 2008;35(4):222-224.
  5. Sharif SN, Darsareh F. Effect of royal jelly on menopausal symptoms: a randomized placebo-controlled clinical trial. Complement Ther Clin Pract. 2019;37:47-50.
  6. Maleki V, Jafari-Vayghan H, Saleh-Ghadimi S, Adibian M, et al. Effects of Royal jelly on metabolic variables in diabetes mellitus: a systematic review. Complement Ther Med. 2019;43:20-27.
  7. Mahboobi S, Jafarnejad S, Eftekhari MH. Royal jelly does not improve markers of glycemia: a systematic review and meta-analysis of randomized clinical trials. Complement Ther Med. 2019;44:235-241.
  8. Lee NJ, Fermo JD. Warfarin and royal jelly interaction. Pharmacotherapy. 2006;26(4):583-586.
  9. U.S. Food and Drug Administration. FDA 101: Dietary Supplements.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.